No More Luxury Journals for One Laureate

Nobel Prize winner Randy Schekman says he will no longer be submitting work to journals like Science, Nature, and Cell.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

The trendiness in research

The trendiness in research topics for grant funding priorities drives more of this hot topics effect than journal publishing - at least for investigators who are not independently funded.

Would like to know how his

Would like to know how his students and post-docs feel about this plan, since career advancement in academia is largely dependent on publishing in those journals.

Only Nobel laureates have the

Only Nobel laureates have the luxury not to publish in luxury journals, once they have successfully played the game that many small labs can't even compete in. I fully applaud the move to open access publication, but the over-reliance on impact factors for grant review, tenure review, and faculty search committees continues to drive this problem. This will likely continue until new metrics are used to judge researchers to create different incentives to publish in open access and social media forums.

Legend has it that Paul Berg

Legend has it that Paul Berg (also a Nobel Laureate) and a group of like-minded scientists, launched the journal 'Molecular and Cellular Biology' in ~ 1980 for precisely the same reason: they were fed up with the politics of publishing in the journal 'Cell'

Its easy for him to say this

Its easy for him to say this too as he has already published in the top-tier journals. The thought is good, however there has to be some method to measure the quality of papers. Top-tier journals are just like cosmo or other celebrity magazines. They allow the average person and myself to keep up with a wide range of topics and are comparable to whats hot and whats not this month. Also, all this is coming from a plant scientists. We are the Roger Dangerfield as science, no respect I tell you. LOL

The selective policies of

The selective policies of these journals some times led to rejections of fundamental discoveries, like the discovery of the Krebs cycle.
Michael Lerman, Ph.D., M.D.

I think that the new model in

I think that the new model in PeerJ (, open access, small fee to publish or join as a member) will be more disruptive to publishing than the open access journal that charge high publication fees. Would love to see Dr. Schekman will publish there!